BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 27166634)

  • 21. IL-37 inhibits invasion and metastasis in non-small cell lung cancer by suppressing the IL-6/STAT3 signaling pathway.
    Jiang M; Wang Y; Zhang H; Ji Y; Zhao P; Sun R; Zhang C
    Thorac Cancer; 2018 May; 9(5):621-629. PubMed ID: 29575809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction of metastatic potential by inhibiting EGFR/Akt/p38/ERK signaling pathway and epithelial-mesenchymal transition after carbon ion exposure is potentiated by PARP-1 inhibition in non-small-cell lung cancer.
    Chowdhury P; Dey P; Ghosh S; Sarma A; Ghosh U
    BMC Cancer; 2019 Aug; 19(1):829. PubMed ID: 31438892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inactivation of M2 AChR/NF-κB signaling axis reverses epithelial-mesenchymal transition (EMT) and suppresses migration and invasion in non-small cell lung cancer (NSCLC).
    Zhao Q; Yue J; Zhang C; Gu X; Chen H; Xu L
    Oncotarget; 2015 Oct; 6(30):29335-46. PubMed ID: 26336823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphatase of regenerating liver-3 inhibits invasiveness and proliferation in non-small cell lung cancer by regulating the epithelial-mesenchymal transition.
    Lin SY; Lee YX; Yu SL; Chang GC; Chen JJ
    Oncotarget; 2016 Apr; 7(16):21799-811. PubMed ID: 26967563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR‑505 inhibits cell growth and EMT by targeting MAP3K3 through the AKT‑NFκB pathway in NSCLC cells.
    Tang H; Lv W; Sun W; Bi Q; Hao Y
    Int J Mol Med; 2019 Mar; 43(3):1203-1216. PubMed ID: 30628663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non‑coding RNA PITPNA‑AS1 silencing suppresses proliferation, metastasis and epithelial‑mesenchymal transition in non‑small cell lung cancer cells by targeting microRNA‑32‑5p.
    Chen G; Zheng Z; Li J; Zhang P; Wang Z; Guo S; Ma J; Shen J; Li H
    Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Remodelin delays non-small cell lung cancer progression by inhibiting NAT10 via the EMT pathway.
    Guo Q; Yu W; Tan J; Zhang J; Chen J; Rao S; Guo X; Cai K
    Cancer Med; 2024 Jun; 13(11):e7283. PubMed ID: 38826095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
    Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
    J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA MALAT-1 competitively regulates miR-124 to promote EMT and development of non-small-cell lung cancer.
    Wu J; Weng Y; He F; Liang D; Cai L
    Anticancer Drugs; 2018 Aug; 29(7):628-636. PubMed ID: 29782349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. STYK1 promotes tumor growth and metastasis by reducing SPINT2/HAI-2 expression in non-small cell lung cancer.
    Ma Z; Liu D; Li W; Di S; Zhang Z; Zhang J; Xu L; Guo K; Zhu Y; Han J; Li X; Yan X
    Cell Death Dis; 2019 Jun; 10(6):435. PubMed ID: 31164631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shikonin Inhibited Migration and Invasion of Human Lung Cancer Cells via Suppression of c-Met-Mediated Epithelial-to-Mesenchymal Transition.
    Hsieh YS; Liao CH; Chen WS; Pai JT; Weng MS
    J Cell Biochem; 2017 Dec; 118(12):4639-4651. PubMed ID: 28485480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FOXD1 Promotes Cell Growth and Metastasis by Activation of Vimentin in NSCLC.
    Li D; Fan S; Yu F; Zhu X; Song Y; Ye M; Fan L; Lv Z
    Cell Physiol Biochem; 2018; 51(6):2716-2731. PubMed ID: 30562753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-135a inhibits migration and invasion and regulates EMT-related marker genes by targeting KLF8 in lung cancer cells.
    Shi H; Ji Y; Zhang D; Liu Y; Fang P
    Biochem Biophys Res Commun; 2015 Sep; 465(1):125-30. PubMed ID: 26235874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. WT1 promotes invasion of NSCLC via suppression of CDH1.
    Wu C; Zhu W; Qian J; He S; Wu C; Chen Y; Shu Y
    J Thorac Oncol; 2013 Sep; 8(9):1163-9. PubMed ID: 23945386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mangiferin inhibits lipopolysaccharide-induced epithelial-mesenchymal transition (EMT) and enhances the expression of tumor suppressor gene PER1 in non-small cell lung cancer cells.
    Lin YS; Tsai KL; Chen JN; Wu CS
    Environ Toxicol; 2020 Oct; 35(10):1070-1081. PubMed ID: 32420661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contribution of upregulated dipeptidyl peptidase 9 (DPP9) in promoting tumoregenicity, metastasis and the prediction of poor prognosis in non-small cell lung cancer (NSCLC).
    Tang Z; Li J; Shen Q; Feng J; Liu H; Wang W; Xu L; Shi G; Ye X; Ge M; Zhou X; Ni S
    Int J Cancer; 2017 Apr; 140(7):1620-1632. PubMed ID: 27943262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of ZNF746 suppresses invasion and epithelial to mesenchymal transition in H460 non-small cell lung cancer cells.
    Kim B; Sohn EJ; Jung JH; Shin EA; You OH; Im J; Kim SH
    Oncol Rep; 2014 Jan; 31(1):73-8. PubMed ID: 24145959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [CacyBP promotes the proliferation and invasion of non-small cell lung cancer].
    Xu YJ; Hu YM; Qin C; Wang F; Cao W; Yu YW; Zhao L; Li J; Chen WQ; Li N; He J
    Zhonghua Zhong Liu Za Zhi; 2021 Sep; 43(9):924-931. PubMed ID: 34530574
    [No Abstract]   [Full Text] [Related]  

  • 39. GINS2 facilitates epithelial-to-mesenchymal transition in non-small-cell lung cancer through modulating PI3K/Akt and MEK/ERK signaling.
    Liu X; Sun L; Zhang S; Zhang S; Li W
    J Cell Physiol; 2020 Nov; 235(11):7747-7756. PubMed ID: 31681988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of the TGFβ Pseudoreceptor BAMBI in Non-Small Cell Lung Cancer Enhances TGFβ Signaling and Invasion.
    Marwitz S; Depner S; Dvornikov D; Merkle R; Szczygieł M; Müller-Decker K; Lucarelli P; Wäsch M; Mairbäurl H; Rabe KF; Kugler C; Vollmer E; Reck M; Scheufele S; Kröger M; Ammerpohl O; Siebert R; Goldmann T; Klingmüller U
    Cancer Res; 2016 Jul; 76(13):3785-801. PubMed ID: 27197161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.